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AIDS in Children:

An Overview of
the Medical,
Epidemiological, and
Public Health

Problems
Ellen R. Cooper, M.D.

Cases of AIDS in children under thirteen years of age have been described since 1982.
Diagnosis is more difficult in children than in adults, owing to the more varied clinical

and the difficulty in interpretation of laboratory tests. Current diagnostic
of HIV infection are reviewed, as well as symptomatology, natural history, and
controversies surrounding management and therapy. Without a full appreciation of the

presentation
criteria

transmissibility of HIV, issues including school and day-care attendance and foster family
placement remain emotionally charged. Conflicting public policies contribute to fears on

the part of the general public. Because of the unique implications for the entire family

when a

child

is

found to have HIV infection, the health care profession has been obliged to

confront complex psychosocial issues unparalleled in modern medicine. The medical

community may provide one safe environment for the family, and so the burden ofproviding support falls to a profession only variably trained and equipped for this task. In the
absence of a vaccine or a cure, public education directed at primary prevention and re-

duction of stigmatization are the keys to true control of the epidemic.

acquired immunodeficiency syndrome (AIDS) was
described
The
males and intravenous drug
was recognized subsequently
first

users.

in

homosexual

in recipients of

It

More reAIDS has been described in the population of infants born to infected mothers. In

infected blood products and in heterosexual partners of infected individuals.
cently,

1982, the

first descriptions

of this illness in children were reported. Retrospectively,

however, cases can be diagnosed since 1979 in this young population. The total number of
pediatric cases of AIDS reported to the Centers for Disease Control

February

The

8,

1988, but by 1991 this

number is expected

be revised,

it

must be underscored

HIV infection may be excluded from the CDC
newborns indicate that
City.

3

2

(CDC) was 820 as of

reach over 3,000.'

CDC has established strict criteria for the case definition of AIDS.

criteria continue to

birth.

to

that

many cases

Although these

of symptomatic

count. Current studies of seroprevalence in

may be HIV-positive at
among newborns in New York
go on to develop symptomatology. The true

in the inner city of Boston,

1

in

55 babies

This approaches the highest rate of seroprevalence

Many, but not

Dr. Ellen R.

all,

of these children will
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statistic with respect to pediatric AIDS will be addressed later in this article.
Widespread recognition of pediatric AIDS as a specific disease entity was delayed for
several reasons. It was difficult to differentiate AIDS from other, already described

impact of this

causes of congenital immunodeficiency syndromes. This differentiation required an elaborate combination of epidemiological observations, pathological studies, and specific

laboratory testing.

The

AIDS

clinical picture of

general, there

remains quite distinct from that in adults. In

in children

Although the well-known opportunistic infections seen

some

AIDS.

a greater heterogeneity in the clinical presentation of pediatric

is

pediatric cases, other infectious agents are

in adult

common.

AIDS

are also seen in

In contrast to adult cases, the

types of pediatric infections first noted were bacterial, usually presenting as sepsis or
meningitis. Primary viral infections with herpes virus or cytomegalovirus were also docu-

mented, but

it

remained

more

retrovirus without

of cases,

There

it

was

difficult to

prove the causal association with the

difficult to establish epidemiological associations early in the epidemic.

also a greater severity of clinical disease in infants with

is

now well-known

Because of this and the relatively small number

specific testing.

AIDS,

especially

when

those without opportunistic infections are compared to adults. Death often occurs early,

sometimes before

criteria are

met to

definitively establish the diagnosis of AIDS, thereby

further complicating epidemiological surveys and investigations. These factors undoubt-

edly contributed to difficulties in accepting early reports of AIDS in infants, and continue
to cloud efforts to define

AIDS

in pediatric patients.

In order to help with the appropriate diagnosis of what was a newly described disease,
the Centers for Disease Control established specific case definition criteria for pediatric

AIDS in

1984. These criteria required modification a year

more clear that the
its

definition.

It

disease differed

from AIDS

later, as it

became more and

in adults. In 1987, the

CDC again revised

developed a definition of AIDS in children under thirteen years of age, as

well as a classification

schema

for other

forms of HIV infection in these children. The

system was designed to aid epidemiological studies, disease surveillance, prevention

programs, and health care planning and

policy.

establishment of public health guidelines.

It is

So established,

it is

less useful clinically,

useful primarily in the

and individual pa-

must be considered separately with regard to management and prognosis.

tients

Current Diagnosis
Ideally,

HIV infection in children is identified by the actual presence of the virus in blood
may be confirmed by culture or antigen detection methods. Since these

or tissues. This

techniques are not standardized tests as of yet, they are not readily available in most centers. In

most areas, physicians must rely on the presence of antibody

in the

serum

as evi-

dence of HIV exposure. This creates a particularly confusing situation when the infant

born

to

an infected mother.

It is

acquired by the infant from the mother while the infant
fifteen

months.

fifteen months,

is

may persist for up to

he or she

considered to be truly infected, regardless of whether symp-

is

at that time.

The problem

HIV

infection.

It is,

arises in the child

under fifteen months of age

asymptomatic infant cannot be used

however, an important marker, since

identify the infant at highest risk. If actual virus cannot
tissue

in utero

demonstrates persistence of HIV antibody for longer than

seropositive. Seropositivity in the

tively establish

is

If the child

toms are present

who

is

currently believed that the maternal antibody passively

by antigen or culture techniques, the child
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be demonstrated

it

to defini-

can certainly

in the

blood or

may be considered infected only

if

there

is

immune deficiency

evidence of cellular and humoral

ogy. These

as well as clinical symptomatol-

symptoms may include progressive neurological

infectious diseases, secondary malignancies, or lymphoid

many

children.

pneumonitis. This

unique condition that causes a chronic and debilitating lung

last entity is a histologically

disease in

disease, specified secondary

interstitial

As noted earlier,

AIDS

the definition of childhood

extremely restrictive as to the type and severity of symptoms; thus, there
porting of this disease in the United States.

The new

will permit the identification of all children with

HIV infection.

It is

also

hoped

that the

classification

AIDS

new schema

schema,

it is

hoped,

as well as other forms of severe

will ensure that all children with

and that these services

infection will be eligible for needed services

remains

an underre-

is

will not

HIV

be limited by

statutory or regulatory definitions of AIDS.

Natural History of Disease

The

not

is

in the congenitally infected infant

seems

to

be four

to six

months,

can be longer than five years in the transfusion-infected child. Most cases of pedi-

it

atric

seroconversion in the pediatric age group

at this time.

The incubation period
but

HIV

natural history of disease after

completely clear

AIDS occur in very young children,

during the

first

Although the
profile has

with 50 percent of pediatric

AIDS diagnosed

year of life and 82 percent by the age of three years. 4
clinical picture of congenital infection

been suggested.

can and does vary significantly, a

Common features include failure to thrive,

lymphadenopathy,

hepato-splenomegaly, chronic diarrhea, mucocutaneous candidiasis, and parotitis. Other

hallmarks are recurrent fevers and bacterial and viral infections as well as
pneumonitis. Children with lymphoid

interstitial

interstitial

pneumonitis tend to become sympto-

matic later and have a better prognosis. Follow-up has not been extensive enough to provide true estimates of mortality, but
reported with

AIDS

are

CDC figures show that over 61 percent of children

known to have died.

5

Transmission
Since

HIV infection in infants and children in this country is a relatively

rence, a clear understanding of the

modes

of transmission

is still

recent occur-

evolving.

It is

well

the major routes for HIV infection are close sexual contact, particumale homosexual contact; the sharing of needles and syringes in intravenous drug
users; and the receipt of blood or blood products.

known that in adults
larly

In the older child,
tion.

HIV can be associated with these same established routes of infec-

The number of AIDS

patients identified during adolescence remains very low; this

may be explained by the long latency period of the virus. Behaviors commonly accepted
as high-risk may be initiated during these years, but symptoms of the disease may not
become evident until young adulthood. Adolescents should therefore be considered a
target population for education, counseling,

and testing. Like

adults, children have

been

HIV during blood transfusions; these cases currently represent 13 percent of
all cases of AIDS in childhood. Another 5 percent of childhood AIDS cases can be attrib-

exposed to

uted to blood products received as treatment for coagulation disorders. 6 There have also

been a few reports of HIV transmission

to children occurring as the result of sexual abuse.

Most children with AIDS, however, are born
virus. This perinatal exposure accounts for

to

mothers

who themselves

carry the

80 percent of the children with AIDS. 7 Such

123

New England Journal of Public Policy

mothers may have a history of intravenous drug use, prostitution, or multiple sexual partners. They may practice no high-risk behaviors but simply originate from particular geographic regions where heterosexual transmission

is thought to play a major role. Here
England we see a great number of patients from Haiti and central Africa, both of
which are considered endemic areas at this time. At the time of their pregnancy, these

in

New

mothers may be symptomatic, have

unaware of their

HIV

AIDS

or

ARC,

or be totally asymptomatic.

Many

are

antibody status, thus increasing the difficulty in recognition of

HIV infection.

children at risk for congenitally acquired

The proof of transplacental transmission of HIV includes

the suggestion by

some

inves-

tigators that HIV-infected infants have characteristic facial features. This would imply an

embryopathy secondary

more

to fetal infection. This suggestion

children will need to be evaluated before

from the

isolated

remains controversial, and

can be substantiated. The virus has been

from umbilical cord blood, and this stands to
from mother to infant. Transmission has been

tissues of fetuses as well as

indicate the presence of viral transmission

documented

it

who have been born by Caesarean section and

in infants

so have had no expo-

sure to vaginal secretions during the birthing process. In addition, infants have been found
to

be seropositive, and

later

symptomatic, even in instances when there has been no post-

natal contact with the biological mother.

The incidence and the efficiency of HIV transmission in utero have not yet been well
It does seem clear at this point, however, that transmission of the virus to the
fetus, while common, is not inevitable. With regard to twins, cases have been reported in

defined.

which only one

infant

was

infected.

By most conservative estimates, however, approxiwho are themselves seropositive are infected

mately 60 percent of infants born to mothers

with HIV. 8 There are no data to suggest that Caesarean section would lower the incidence
of HIV transmission from mothers to infants, but this
raised in the medical community.

Many

is

certainly a question that has

studies are being conducted

been

around the world

in

order to obtain better answers to this very important question. In Boston alone, several
studies are trying to investigate the efficiency of transmission, the presence or possible

may impact on that transmission, and the effect that
may have on the progression of the disease in a seropositive woman.

importance of other cofactors that

pregnancy

itself

Other types of perinatal transmission of HIV must be considered, although they probably do not play as major a role as transplacental passage of virus. These include passage

of the virus via infected breast milk. In support of this as a potential risk, there has been a
report of a child born by Caesarean section to a mother

with

HIV after the delivery of the infant.

who

received blood contaminated

This child seroconverted, with the only identifi-

able exposure being breast milk. 9

Although actual infective virus seems
cases, there

born

to

is

to

be transmitted

in approximately

60 percent of

a passive transfer of maternal antibody in virtually 100 percent of infants

mothers

who are themselves

seropositive. This raises all sorts of social, political,

and medical dilemmas, since currently we are unable

to identify those infants

who are

most likely to become symptomatic. In those infants who are not truly infected, maternal
antibody seems to decrease over months, until finally the babies become seronegative.
Because this may take up to fifteen months, decisions regarding day care, immunizations,
and treatment modalities often become an issue before the question of true infectivity can
be resolved satisfactorily.
The actual incidence of HIV infection in infants will depend on several factors. These
include the number of children born to HIV-infected women as well as the prevalence of
seropositivity in the population of women

who are of childbearing
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age.

The prevalence of

HIV has been clearly shown to be dependent on the

subpopulation group and the geo-

graphic area studied. For example, 59 percent of intravenous drug users in

New York City

are seropositive, while only 20 to 25 percent of intravenous drug users in Boston

be seropositive. 10 In Worcester,
found

to

this

seem

to

percentage was even lower but has recently been

be increasing rapidly." As the number of infected

women continues to rise, we

can expect the incidence of HIV-infected infants to increase enormously.

The

possibility of transmission of virus to family

been a particularly sensitive

issue.

To

members and household

contacts has

date, in spite of exhaustive studies, there has

been

no evidence to support the horizontal transmission of HIV with casual or usual household
contact. In one family study, a mother who cared for her transfusion-infected child did
seroconvert, but this was after very heavy and unusual exposure to blood, secretions, and
12
excreta without proper hand washing or the use of gloves. In another study, a brother of

an HIV-infected child did become seropositive. 13 The only unusual exposure that was

documented was a bite from the infected child. The causal relationship has not been posidetermined in this case. Although HIV has been cultured from both tears and saliva, these are considered to be fluids with a very low titer of virus, and to date there have
been no reports of transmission via exposure to these secretions.
A question has been raised as to the susceptibility of the infant and the young child to
HIV. Although more investigation is needed before a clear understanding can be acquired,
it seems that increased susceptibility may indeed be a factor, as evidenced by several epidemiological studies. In a study of transfusion-related AIDS, infants accounted for 10
tively

percent of cases even though they had received only 2 percent of the total number of blood
transfusions.

There also seemed

to

be a shorter latency period between exposure

and onset of symptoms. This may be attributed to the

relative size of transfusion,

to virus

and

therefore the load of virus.

Controversial

Management Modalities

The mainstay of the management of the child with HIV infection has been largely a supPrompt recognition and treatment of all infections are of the utmost importance, as is the maintenance of good nutritional status. However, a few issues have
prompted debate among the health care professionals who are caring for these children.
The utilization of immunizations has been controversial in the population of children
infected with HIV. The potential hazards of the vaccines themselves must be weighed
against the risk from the diseases they are designed to prevent. It has been suggested that
the stimulation from the vaccine itself may cause a deterioration in the clinical status of an
portive one.

infected child.

The

risk of live virus vaccines such as

MMR (measles/mumps/rubella) and oral polio

vaccine has been specifically debated. In general, children

who are immunocompromised

by other deficiencies or by chemotherapeutic ablation are at risk for acquiring the disease
from a vaccine of this type. These vaccines are therefore not recommended for this population.

With regard

to HIV-infected children specifically, several retrospective studies

have investigated the outcome when seropositive children were inadvertently given oral
polio vaccine. Because no

ill

effects have

infants are truly HIV-infected, current

child

is

asymptomatic

it

may be

been reported, and because not

recommendations from the

all

seropositive

CDC suggest that if the

safe to administer routine immunization. Specific

recom-

mendations of the national Immunization Practices Advisory Committee in regard to the

immunization of HIV-seropositive children have been published, but differences of opin-
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ion

still

exist.

14

Some

feel that the theoretical risk is quite substantial

and

that until a large

number of children have been studied, it may be wise to be conservative. At Boston City
Hospital, we recommend the use of inactivated polio vaccine in all seropositive children,
whether symptomatic or not. We feel more comfortable with this practice not only with
respect to the infant's safety, but also because these children often have infected caretakers. Polio virus
this

is

shed in the stool for weeks to months after oral vaccine

would put infected guardians

at

some

given, and

is

We remain consistent in our view

risk as well.

of the risk associated with live virus vaccine and thus withhold measles/mumps/rubella

immunizations from seropositive children as well, although

this represents

no

risk to

other family contacts.
Inactivated polio vaccine

is

when it is available, it is more
where immunization practices are being debated,
vaccine must be weighed against the relative accessibility of

often difficult to obtain;

costly than oral, live vaccine. In areas

the theoretical risk of the oral

the inactivated form. Other routine vaccinations of childhood should be given, although

some data suggest

that the vaccine

may

When exposure to chicken pox occurs,
nization, although efficacy has not yet

The biggest problem

in the

recurrent infections that

not result in the production of functional antibody.
these children should also be given passive

management of the

may progress

strategies to prevent this have not yet

immu-

been determined.
to sepsis,

child with

HIV infection is control of the

pneumonia, and meningitis. Optimal

Many

been established.

the use of prophylactic antibiotics, but these carry with

centers have

them the

recommended

risk of side effects,

poor

compliance, and the emergence of resistant bacterial strains.

Given the predisposition of children with

HIV infection to develop recurrent bacterial

infections, the use of prophylactic intravenous

gested.

immunoglobulin (TVIG) has been sug-

A few studies have been reported, but no firm data that are based on controlled

clinical trials are available.

Because of a lack of other effective therapies, these

subjective reports resulted in fairly widespread use of this preparation.

early,

Now, with

the

number of HIV-infected children climbing rapidly and the average cost per child of
monthly IVIG totaling approximately $30,000 per year, there is pressure to demonstrate
efficacy. In addition, some feel that monthly visits to the hospital for intravenous therapy

may represent undue exposure to other infectious agents.
funded by the National

Institutes of

Health

is

trial to

address this issue rapidly and accurately.

cine

actively participating in this trial.

is

Special Antiviral Therapies: Choices

The

The Boston University School of Medi-

and Dilemmas

devastating and frequently occurring central nervous system disease in children with

HIV

infection has to be taken into consideration

Any

for study.
little

antiviral

when

a specific antiviral agent

is

chosen

drug that does not penetrate the blood brain barrier may be of

benefit in the pediatric age group.

As new
will

Currently, a multicenter study

executing a double-blind placebo-controlled

antiviral agents

be important

to

become

available for study in children with

HIV infection,

have modes of comparison already established. In

it

this way, all chil-

dren will be able to receive therapy already proven to have some efficacy, either in control
of symptoms or in activity against the retrovirus.
infection

would be

The

ultimate goal of therapy for

to control or ablate the infection altogether,

vidual's ability to reconstitute normal

immune

126

function.

HIV

and also restore the

indi-

Although there are many potential targets for antiviral drugs, most recent efforts have
at inhibiting the DNA polymerase that is unique to the retrovirus. Of the

been aimed

candidate antiviral agents for testing in children, the most publicized has been Azidothy-

midine (AZT). Preliminary

trials

have already begun in several centers so that optimal

dosage regimens can be established. Although
adults with

quite toxic, and
tate

most patients taking

blood transfusion. Other

tion, there

may be other

it

cell lines

of the bone

lifelong therapy.

It is

not without problems.

marrow may

not

known how

also be affected. In addi-

and central nervous

AZT must therefore be considered

children will respond to this drug.

Severe opportunistic infections with

viral, bacterial,

and parasitic pathogens have

active research in the area of new therapies for these specific pathogens as well.

New drugs have been developed and tested for cytomegalovirus,
tis

It is

HIV antigen has been demonstrated to decrease during

returns with cessation of treatment.

it

it is

have developed anemia severe enough to necessi-

side effects, such as nausea, vomiting,

system disturbances. Although

AZT therapy,

spawned

AZT has been shown to be efficacious in

AIDS and has been licensed for clinical use,

carinii infections.

herpes, and Pneumocys-

While these therapies may have no effect on

HIV per se,

they have

had a great impact on the care of the infected patient.

Many AIDS patients,

both adult and children, have received new therapies of one sort

or another on experimental protocols after informed consent has been obtained. This has
created a legal dilemma, especially in regard to the pediatric patient.

Many of these chil-

dren are in foster care families, with legal custody being in the hands of the

state social

up many

on the

services department. This brings

legal questions of risk

and

liability

part of the governmental agency that grants permission for participation in experimental
protocols.

Of course,

this

problem

is

unique to pediatrics, since the patient

fore unable to give informed consent

on his or her own behalf.

difficult to obtain permission in circumstances such as these.

protocols

become

available,

a minor and
it

is

need

to

there-

has been

However, as more and more

and as the number of children with devastating disease

creases, these "experimental" therapies will
tions regarding liability will

is

Traditionally,

become standard of care. The

in-

legal ques-

be weighed against the ethical issue of withholding

possible effective therapy from children with otherwise fatal disease.

Public Health and Policy Issues
Education and day care of children with

HIV infection is an emotionally

charged topic,

because of the severity of disease and the fear on the part of the general public. Pressure

on those who make public policy has prompted hasty and sometimes overly conservative
decisions. It is important to underscore again that there has been no documentation of

HIV transmission in the school,

at

day care, or in any other casual

setting.

Current guidelines from the Centers for Disease Control confirm that school-age
dren

who have evidence of HIV

setting. Certain

chil-

infection can be comfortably included in the classroom

unusual circumstances, however, do require special consideration in

this

who have oozing lesions or recurrent bleeding or who lack
control of their bodily secretions may pose a greater risk to their classmates. Moreover,
children who may not be developmentally appropriate and who may therefore exhibit
abnormal behavior, such as excessive biting, may need to be excluded from the general
regard. For example, children

classroom. Although

it is still

unclear whether even these children truly represent a sig-
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nificant risk to their classmates, the Massachusetts Governor's Task Force

upheld the

on AIDS has

CDC guidelines.

Currently, the true responsibility for creating guidelines to deal with this sensitive issue

The

falls to local authorities.

guidelines are

much more restrictive in some states than in
when possible. These discrepancies further

others. Still other states have avoided the issue
fuel apprehensive parent

and

by underscoring the uncertainty on the part

political groups,

of policymakers as to the real danger that might exist. The Report of the Surgeon General's

Workshop on Children with

HIV Infection and Their Families,

1987, suggests that the decision about whether to attend school
ual's physician.

15

on a judgment as

is

published in July

best left to the individ-

This decision should be based on the general health of the individual and
to

whether school attendance would indeed pose a risk

way of excessive exposure

to infectious agents.

The report

states that

to the patient

by

under ideal circum-

stances, an individual at the school should be aware of the diagnosis; however, the need
for confidentiality gives children the right to have the information withheld

school.

The report emphasizes

that realistic guidelines

from the

based on best current knowledge

should be considered by school boards, principals, and physicians. Resources should be

developed for dissemination and implementation of new information as

The report

ble.

it

becomes

availa-

also deals with the issue of day care for the preschooler or the develop-

mentally delayed older child.

It

suggests that these toddlers be allowed to attend day care

unless scientific evidence suggests that exposure of this sort could place at risk the other,

uninfected children. So

far,

investigators have

been unable

and

to collect this evidence,

for

reason these children should not be excluded from day care arrangements.

this

In Massachusetts, conservative guidelines exclude children under three years of age

with evidence of HIV infection from attending a group day care setting. This raises issues
of ethical, political, and economic importance. While health care workers try to encour-

age

HIV testing in high-risk populations,

the day care guideline represents yet another

negative incentive to families. With no alternative to day care, one or both parents

forced out of the workplace to stay at
adult

home with the child. Coupled with the

may be symptomatic from HIV

stressful situation.

infection, this adds yet another

Because the guidelines pertain

dence of maternal antibody (since

it

may

those with true infection), the problem

is

to those infants

burden

may be

fact that

who merely

one

an already

to

have evi-

not be possible to distinguish these children from

aggravated

still

further.

Counselors and health

care workers are often faced with a difficult dilemma. Reporting to day care organizers

may

represent a breach of confidentiality, and so infringements of state regulations

go uncorrected anyway. The question of legal obligation

in these

circumstances

and ultimately may have to be resolved by the judicial system.
Another area where lack of federal guidelines has forced local authorities

is

may

a most

difficult one,

cult decisions is foster care.

when

a child

is

Because

legal custody is in the

placed in foster care, the question of informed consent for

sensitive one. Physicians can obtain approval for testing
cies, but confidentiality guidelines vary. In

some

to

make diffi-

hands of a government agency

from most

HIV testing is a

social service agen-

cases, foster families are not informed of

the test results. This raises obvious questions of liability, since precautions for family

members and medical care

for the child in question

may

not be adequately addressed.

Psychosocial Issues and Counseling

Aside from

all

of the

new and unusual questions that have been raised with regard to HIV,
new challenges to the health care system. The stigma-

the psychosocial issues have created
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tization of this disease has complicated the health
uals.

and social care of the infected individ-

School-age children have become the focus of teachers', other pupils', and neighbors'

Ostracism and resultant low self-esteem have often been the outcome of this public

fears.

frenzy and

fear.

Adolescents

who have acquired this

disease by engaging in "high-risk

behaviors" must deal with admissions to the behaviors in addition to the disease

itself.

Well-publicized incidents of discrimination, accompanied at times by acts of violence,

have created an environment in which the family with an infected individual has sometimes chosen to be totally anonymous rather than search for help. This reduces the possibility

of psychiatric, social service, religious, or community support.

In addition, the misconceptions within different cultural, ethnic, and even

community

groups have further complicated the feeling of alienation on the part of the afflicted family.

Some

individuals have been forced out of housing, others turned away by their family

or friends. In some cases, churches have been afraid to give comfort to these families,

even refusing to house funeral or memorial services. In addition to the obvious psychosocial

burden on the family,

munity, since

it is

this places a great stress

and responsibility on the medical com-

often only through this system that any support

may be obtained.

This

is

considered a "safer" environment in which to vent frustrations, anger, and sadness sur-

means

this burden alone.
up other problems for the family. Many of
these children are already the victims of drug-using families and low socioeconomic status. When a mother is told that her infant is seropositive, she must also be told of the like-

rounding the diagnosis; but

it

that the

medical staff often accepts

Identification of a seropositive infant brings

lihood that she herself is infected with HIV. This message must convey the serious and
usually fatal nature of the illness in the infant; the likelihood of infection and potential for
illness

and death

in the parents; the

need for changes in sexual expression in order

to

prevent subsequent transmission; and the possibility of avoidance of future pregnancies.
Fear, guilt, and sadness further complicate an already complicated scenario.

An older,

uninfected sibling must face the possibility of losing not only a sibling, but both parents as

been described or paralleled

well. This type of "family disease" has not

in

modern medi-

cine.

Any

discussion of the psychosocial issues regarding

HIV infection must include the

medical team and other support services through which care

is

provided for the child.

Because of the problems just discussed, caring for these patients can be a draining experi-

who usually see patients improve under their care. Even for
who care for chronically and terminally ill children, the family

ence for the pediatricians,
physicians and others

nature of this disease can be overwhelming.

The

social

problems are far-reaching, and the

on the part of the medical team can reach a point of desperation. A
large number of people are needed to care for a particular child, owing to the multidisciplinary nature of the required services, and this can lead to miscommunications. We have
feeling of impotence

found that regularly scheduled discussion and support groups are necessary for dealing

more symptomatic and hospinumber of infected children

with this situation, especially as a particular child becomes
talizations

become more frequent and prolonged. As

we will have to look to other techniques
among health care workers.

increases,

to

the

reduce burnout and depression

A Comprehensive Approach to the Problem
Owing

to the

infection,

unique problems presented to the medical community by the child with

new approaches

to the organization

HIV

and execution of care have been attempted.
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The Boston Comprehensive
and toddlers with

HIV

Pediatrics

infection

who

AIDS Program is the residential unit for infants

cannot be cared for

at

home. The program functions

within the Boston City Hospital grounds, with support from the Massachusetts Depart-

ment of Public Health and the Boston Department of Health and Hospitals. It is set up as a
home for these children until their parents are able to care for them or until other parenting arrangements can be made.

program opened

in

It

currently has a four-bed capacity, and, almost since the

February 1987, there has been a waiting

list

for these beds. Respite

workers provide direct child care on a twenty-four-hour basis. The philosophy of the

program supports and facilitates the creation of a warm, caring environment. Through the
combined efforts of a program coordinator, a social worker, a registered nurse, eight
child health care workers, and volunteers, this program offers each child a specialized
program for promoting maximum wellness. When it is appropriate, families are included
in activities. Overnight visits, which allow the parents to learn to care for their child's
special needs,

may

facilitate

developed for children

preparations for eventual discharge. This residential unit was

who are medically

stable

When a child has an acute problem for which
fer to

an inpatient ward

is

arranged. This separation allows for a normalization of life for

children while they are in the residential

Also

at

and who need only "home medical care."

she or he needs ongoing medical care, trans-

Boston City Hospital

is

facility.

housed Boston's only outpatient medical

to deliver multidisciplinary care to pediatric patients with

clinic

designed

HIV infection. Care is provided

through a team approach, and staffing consists of infectious disease specialists as well as
other subspecialty physicians. All children are followed with nutritional and developmental

assessments. Social service and educational counseling are available to

all

patients as

Communication with primary care physicians who have referred patients is maintained, and the program works in close association with the Boston City Hospital Adult
AIDS Program, further establishing a family-based treatment program. The same team
follows the patient and helps direct decision making when the child is admitted to the
well.

hospital, thus providing care of these families. In addition, all appropriate treatment pro-

tocols are

made available to

these patients and their families.

Control of the Epidemic
Currently, very exhaustive attempts are being

made to develop

a vaccine that will prevent

HIV infection in individuals who have not yet been exposed. Numerous problems exist,
making the search

for

an effective vaccine a very difficult one. The effort

is

complicated

by the diversity of subtypes of the virus and by the lack of knowledge regarding the actual
role of antibodies and cell-mediated

immunity

in the defense against HIV.
on candidate vaccines is to develop a vaccine that will induce neutralizing antibody. It has been shown, however, that most patients
with HIV infection have neutralizing antibody that is not effective in preventing AIDS.

The

objective of most investigators working

may exist in conjunction with virus latency to "protect"
HIV from the immune system. At the present time, it is not known how vaccination will

Direct cell-to-cell spread of virus

effect either seronegative or seropositive donors.

age of chimpanzees; therefore,
seronegative

it

will probably

Animal

testing is

be necessary

to test

hampered by a shortmost vaccines in HIV-

human volunteers.

We are a long way

from being able

to rely

on a vaccine

to control this epidemic, so

other avenues must be explored.

Although universal blood screening of blood and blood products for

130

HIV has not elimi-

.

.

nated the risk of transfusion-associated acquisition of HIV,

it

was an important step

in

decreasing the number of new cases. Because of the long latency period of the virus, however,

new

some time.
number of births

transfusion-related cases will continue to be diagnosed for

Prevention of perinatally acquired disease will depend on the
infected

women.

their children

Efforts to identify and educate infected

must be aggressive.

to

HIV-

women who can transmit HIV to

Women who are at high risk must be counseled to un-

dergo voluntary screening, and they must be educated about the risks associated with

pregnancy

in the seropositive mother.

Of course,

education must also focus on behavioral

modification, including avoidance of high-risk sexual activities and of intravenous drug
use.

Clearly, populations that are already at high risk

the true spread of the

AIDS

must be counseled and educated. But

epidemic will not be controlled

made aware of the risks. Containment of this disease will
changes in behavior and

lifestyle so that the

until the general public is

rest

on our

ability to effect

chain of transmission can be broken.

The

mass media, which often emphasize the sensational aspects of the AIDS epidemic, must
educate the public so that fear does not spawn drastic policy measures that are unwarranted in terms of what is known about the actual risk.
Significant portions of the population, including intravenous drug users, adolescents,

and persons with language barriers, are not being reached with the educational message
conveyed through traditional media. The techniques of marketing research should be used
to identify the

most effective means of communicating with

tion. Alternative

all

segments of the popula-

communication resources should be explored. Only

in this

way can

the

stigmatization be reduced, thus allowing affected individuals to openly be counseled,

and provided with care. Without these measures, the number of HIV-infected

tested,

adults, children,

and infants will continue

to

grow to even more

tragic proportions.

^
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Glossary

ADCC.

Antibody -dependent cell-mediated

Adjuvants.

cytotoxicity.

Materials used with vaccines to enhance the activity of a
vaccine.

Cytotoxic

(killer) T-cells.

A component of the immune response involving a subgroup
of lymphocytes that

Lymphokines.

kill

virus-infected cells.

Chemicals produced by lymphocytes

to

communicate with

other lymphocytes.

Transmucosally.

Across mucous membranes such as those lining the vagina

and rectum.
Virion.

A single virus particle.
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